During the past decade, Novant Health Urogynecology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Novant Health Urogynecology" are "Pelvic Organ Prolapse" (1 trials) and "Stress Urinary Incontinence" (1 trials). Many other conditions were trialed in "Novant Health Urogynecology" in a lesser frequency.

Most popular intervention types in "Novant Health Urogynecology" are "Device" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Desara® Blue Transobturator Sling" (1 trials), "Desara® One Single Incision Sling" (1 trials), "Native Tissue Repair Anterior" (1 trials), "Native Tissue Repair Posterior" (1 trials) and "Restorelle Direct Fix A" (1 trials). Other intervention names were less common.

The vast majority of trials in "Novant Health Urogynecology" are 2 trials for "Female" genders.

Currently, there are NaN active trials in "Novant Health Urogynecology". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Novant Health Urogynecology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Novant Health Urogynecology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".